IRIDEX introduces New Instruments for Retinal Surgery
MOUNTAIN VIEW, CA, June 15, 2010—IRIDEX Corporation (Nasdaq: IRIX) today
announced the addition of a unique line of vitreoretinal instrumentation to its ophthalmic
product portfolio. As a result of the acquisition of RetinaLabs by IRIDEX, surgeons now
have ready and convenient access to an array of instruments and adjunct products
offering unmatched clinical benefits for use during vitreoretinal procedures in the
operating room and the surgery center. All of the acquired RetinaLabs products are
covered by one or more U.S. and international patents, and available for immediate
shipment and use within the United States.
Products introduced into the IRIDEX surgical portfolio include:
♣ MoistAir™ Humidifying Chamber, a sterile, single use product that provides
humidified air to the eye during fluid-air exchange. The use of humidified air can
substantially reduce the dehydrating effects of dry air. Published clinical studies
have shown that humidified air: delays lens feathering; protect the corneal
endothelium; delay pupillary miosis; and, may prevent visual field defects after
macular hole surgery.
♣ GreenTip™ Soft Tip Cannulas, sterile, single use devices that effectively
enhance the surgeon’s visibility during retinal surgery. A complete line of
GreenTip Cannulas are available in 20, 23 and 25 gauge sizes, and with regular
and brush tip styles.
♣ Endoview™ Sapphire Lenses provide superior clarity and optical performance,
with the capability for extreme wide-angle viewing that is particularly useful
during fluid-gas exchange procedures. These durable, autoclaveable lenses are
manufactured from high refractive index single crystal sapphire and are scratch
and chip resistant. Available lenses include plano, prismatic, biconcave, macular
magnifying, and asymmetric biconcave lenses.
“This line of surgical instrumentation demonstrates our commitment to innovation and
improved surgical outcomes for our customers and their patients,” commented Frank
Tighe, Vice President of Vitreoretinal Instrumentation. “The addition of these new
instruments complements our existing family of lasers and EndoProbe®
endophotocoagulation handpieces, expanding our product offering to retinal surgeons.”
“I am excited to see a new home for the RetinaLabs portfolio of instruments at
IRIDEX. Together they represent some of the most innovative and unique vitreoretinal instruments
on the market. I believe IRIDEX will expand their distribution as well as
provide a much needed venue for development of advanced vitreoretinal
instrumentation,” commented Eugene de Juan, MD, RetinaLabs cofounder and Professor
of Ophthalmology at the University of California San Francisco.
For more information, please contact Lynh Severson by emailing lseverson@iridex.com.